fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Semaglutide Once Again Linked to
Description
Find out who shouldn't take Mounjaro or Wegovy
What are GLP-1s?
Suffering from chronic fatigue from aching, tingling legs at night
Major Update in Obesity Care: New ADA Guidelines (2026) The American Diabetes Association has released new, evidence-based guidance on the pharmacologic treatment of obesity and this is not a minor update
Menopause triggers metabolic shifts that make weight management harder for many women
This prefilled injection pen is typically administered once weekly as directed by a healthcare professional
